ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients.

Chen, Ming-Huang

ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2016 - 4225-35 p. digital

Publication Type: Journal Article

1557-3265

10.1158/1078-0432.CCR-15-1800 doi


Adult
Aged
Aldehyde Oxidoreductases--genetics
Antimetabolites, Antineoplastic--pharmacology
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor
Cell Line, Tumor
Cell Movement--genetics
Cell Survival--genetics
Cholangiocarcinoma--diagnosis
Cisplatin--pharmacology
Deoxycytidine--analogs & derivatives
Drug Resistance, Neoplasm--genetics
Enzyme Activation
Female
Gene Knockdown Techniques
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Protein Isoforms
Proto-Oncogene Proteins c-met--genetics
Gemcitabine